glp-1/gip agonists TrimRX Understand GLP-1/GIP Dual Agonist Tirzepatide

These findings support their use as a valuable adjunctive obesity management medication (OMMs) in post-bariatric care, though long-term adherence and cost-effectiveness require further investigation

29 These results suggests that the reported negative retinopathy outcomes observed in some studies may not be specific to the GLP-1/GIP agonists, but rather scenarios where their use resulted in larger drops in A1c

The First Wave: Older GLP-1 Medications Before semaglutide stole the spotlight, several other GLP-1 agonists were used primarily for diabetes management, with modest weight loss benefits

This study showed a significant association between GLP-1 RA treatment and an 98% increased risk of any psychiatric disorders

Nature 619 , 19 (2023)